Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 655-661, May 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubini, J. R.
Right arrow Articles by McCall, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubini, J. R.
Right arrow Articles by McCall, M. S.

Inhibition of Tritiated Thymidine Incorporation into DNA by Alkaline Phosphatase Preparations*

Joseph R. Rubini{dagger}, Sue Keller and Mary Sue McCall

( Veterans Administration Hospital and the University of Texas Southwestern Medical School, Dallas, Texas)

A factor present in homogenized normal human blood leukocytes containing alkaline phosphatase activity was shown to be effective in depressing the incorporation of TDR-H3 into DNA-H3 when preincubated with dog bone marrow, lymph, and human chronic granulocytic leukemia cell suspensions. Human donor blood buffy coats were extracted, and an approximately 200-fold purified preparation of leukocyte alkaline phosphatase was prepared by the method of Traubowitz. The purified leukocyte alkaline phosphatase preparation readily dephosphorylated thymidylic acid and was free of detectable thymidine phosphorylase activity. This purified leukocyte enzyme preparation was also seen to be active in depressing the incorporation of TDR-H3 into DNA-H3 when preincubated with the intact proliferative test cells. The active factor present in the purified alkaline phosphatase preparation was heat-labile, nondialyzable, and appeared to be inhibited by 10-3 M Zn ion—all properties shared by alkaline phosphatase. It is suggested that the identity of this inhibiting factor is the enzyme alkaline phosphatase and that entrance of this enzyme into proliferative cells occurred via pinocytosis. A mechanism of action of alkaline phosphatase is proposed in which its capacity to dephosphorylate thymidylic acid monophosphate to thymidine could divert significant amounts of this essential deoxynucleotide from DNA formation. This diverting effect of alkaline phosphatase on thymidylate may play an important role in controlling DNA synthesis and growth.

* Supported in part by U.S.P.H.S. Grant No. C 5325 and Atomic Energy Commission Contract No. AT (40-1) 2731.

{dagger} Present address: Hematology Section, Veterans Administration Hospital, Coral Gables, and University of Miami School of Medicine, Miami, Florida.

Received 9/25/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.